Advertisement

Clinical Rheumatology

, Volume 3, Issue 3, pp 375–379 | Cite as

A case of scleroderma with Sjögren's syndrome developed after mammoplasty

  • M. Nobunaga
  • K. Oribe
  • S. Ohishi
Case Reports

Summary

A case of scleroderma and Sjögren's syndrome, which occurred 9 years after mammoplasty, was reported. The association between mammoplasty and connective tissue disorders was considered to be more than coincidental. The prolonged hypersensitization by injected material may be responsible for the development of connective tissue disorders, that is, a human adjuvant disease.

Key words

Human adjuvant disease Mammoplasty Scleroderma Sjögrn's Syndrome 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abe, T. Human adjuvant disease. J. Keio Med. Soc. 1972, 49, 177–183.Google Scholar
  2. 2.
    Taura, N., Usa, T., Eguchi, K. A case of human adjuvant disease (abstract). J Jap Soc Intern Med, 1976, 65, 840–841.Google Scholar
  3. 3.
    Kumagai, Y., Abe, C., Shiokawa, Y. Scleroderma after cosmetic surgery: four cases of human adjuvant disease. Arthritis Rheum, 1979, 22, 532–537.Google Scholar
  4. 4.
    van Nunen, S.A., Gatenby, P.A., Basten, A. Postmammoplasty connective tissue disease. Arthritis Rheum, 1982, 25, 694–697.Google Scholar
  5. 5.
    Fukuda, Y., Oohashi, Y., Kitamura S. et al. An autopsy case of adjuvant disease occurred 22 years after the mammoplasty. Annual report 1977, Vascular lesion of collagen diseases research committee (Edited by Y. Shiokawa), Japan, The Ministry of Health and Welfare, 1978, 98–102.Google Scholar
  6. 6.
    Miyoshi, K., Miyaoka, T., Kobayashi, Y. et al. Hypergammaglobulinemia by prolonged adjuvanticity in men. Disorders developed after augmentation mammoplasty. Jap Med J, 1964, 2122, 9–14.Google Scholar
  7. 7.
    Pearson, C.M. development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med, 1956, 91, 95–101.Google Scholar
  8. 8.
    Miyoshi, K. Postmammoplasty disorder as an adjuvant disease of man. Shikoku Acta Med, 1973, 5, 785–794.Google Scholar
  9. 9.
    Yoshida, K. Postmammoplasty disorder as an adjuvant disease of man. Shikoku Acta Med, 1973, 29, 318–332.Google Scholar
  10. 10.
    Shiokawa, Y., Nishino, Y., Shimada, S. et al. Cases of the so-called adjuvant disease due to mammoplasty. Clin Immunol, (Tokyo) 1972, 4, 389–396.Google Scholar
  11. 11.
    Okada, M., Isoda, K., Yamazaki, S. et al. An autopsied case of adjuvant disease (abstract). J Jap Soc Intern Med, 1972, 61, 229–230.Google Scholar
  12. 12.
    Cohen, A.S., Reynolds, W.E., Franklin, E.C. et al. Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis, 1971, 21, 643–648.Google Scholar
  13. 13.
    Masi, A.T., Rodnan, G.P., Medsger, T.A. et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis, 1981, 31, 1–6.Google Scholar
  14. 14.
    Ropes, M.W., Bennett, G.A., Cobb, S. et al. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis, 1958, 9, 175–176.Google Scholar
  15. 15.
    Sharp, G.C., Irvin, W.S., Tan, E.M. et al. Mixed connective tissue disease an — apparently distinct rheumatic disease syndrome with a specific antibody to an extractable nuclear antigen (ENA). Am J Med, 1972, 52, 148–159.Google Scholar
  16. 16.
    Shearn, M.A. Sjögren's syndrome. Philadelphia, Saunders, 1971.Google Scholar
  17. 17.
    Rodnan, G.P., Benedeck, T.G., Medsger, T.A. Jr. et al. The association of progressive systemic sclerosis (scleroderma) with coal miner's pneumoconiosis and other forms of silicosis. Ann Intern Med, 1967, 66, 323–334.Google Scholar
  18. 18.
    Guenter, G., Schuchardt, E. Silikose und progressive Sklerodermie. Dtsch Med Wochenschr. 1970, 9, 467–468.Google Scholar
  19. 19.
    Freneaux, B., Freneaux, J., Buyse, N. et al. L'association silicose sclerodermie. Nouv Presse Med, 1975, 4, 2087–2090.Google Scholar
  20. 20.
    Beck, B., Irmscher, G., Zschunke, E. Silikose und Sklerodermie-Versuch einer Synopsis. Z Gesamte Inn Med, 1976, 31, 494–496.Google Scholar
  21. 21.
    Pernis, B., Paronetto, F. Adjuvant effect of silica (tridymite) on antibody production. Proc Soc Exp Biol Med, 1962, 110, 390–392.Google Scholar
  22. 22.
    Miyoshi, K., Miyaoka, T., Ueshima, K. et al. Silicosis as a human adjuvant disease. Jap Med J, 1965, 2170, 6–11.Google Scholar
  23. 23.
    Alarcon-Segovia D., Ibanez G., Hernandez-Ortiz J et al: Sjögren's syndrome in progressive systemic sclerosis (scleroderma). Am J Med, 1974, 57, 78–85.Google Scholar
  24. 24.
    Cipoletti, J.F., Buckingham, R.B., Barnes, E.L. et al: Sjögren's syndrome in progressive systemic sclerosis. Ann Intern Med, 1977, 87, 535–541.Google Scholar
  25. 25.
    Lawley, T.J., Peck, G.L., Moutsopoulos, H.M. et al. Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med, 1977, 87, 707–709.Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • M. Nobunaga
    • 1
  • K. Oribe
    • 1
  • S. Ohishi
    • 1
  1. 1.Department of Internal Medicine, Medical Institute of BioregulationKyushu UniversityBeppu 874Japan

Personalised recommendations